Helping Children Receive an Earlier Autism Diagnosis

For ParentsFor Providers

Earlier Diagnosis + Earlier Intervention = Better Outcomes

A NEW DIAGNOSTIC TOOL

Our NPDX ASD test may lead to an earlier diagnosis for children with autism spectrum disorder (ASD).

Learn More
Earlier access to specialty care and treatments improve outcomes

Posters & Publications

Posters

NeuroPointDX, through its parent company Stemina Biomarker Discovery, has published papers in peer-reviewed journals and presented research at meetings around the world.

Identification of Neurotransmitter-Associated and Other Metabotypes: Further Stratification of the Children’s Autism Metabolome Project (CAMP) ASD Subjects – INSAR 2019 [PDF]

Presented at the 2019 Annual Meeting of the International Society for Autism Research in Montreal, Ontario, Canada in May 2019. The Children’s Autism Metabolome Project (CAMP, ClinicalTrials.gov: NCT02548442) recruited 1,100 children for metabolomic analyses to identify altered metabolism associated with ASD. Previous research identified ASD subjects associated with branched-chain amino acid (BCAA) dysregulation. With this[…]

Read more

Publications

NeuroPointDX, through its parent company Stemina Biomarker Discovery, has published papers in peer-reviewed journals and presented research at meetings around the world.

Identification of Neurotransmitter-Associated and Other Metabotypes: Further Stratification of the Children’s Autism Metabolome Project (CAMP) ASD Subjects – INSAR 2019 [PDF]

Presented at the 2019 Annual Meeting of the International Society for Autism Research in Montreal, Ontario, Canada in May 2019. The Children’s Autism Metabolome Project (CAMP, ClinicalTrials.gov: NCT02548442) recruited 1,100 children for metabolomic analyses to identify altered metabolism associated with ASD. Previous research identified ASD subjects associated with branched-chain amino acid (BCAA) dysregulation. With this[…]

Read more

NEWS

Video: NeuroPointDX Presents at TACA East Coast 2019

Metabolism Based Diagnosis and Precision Medicine for Autism Spectrum Disorders Presented at The National TACA Autism Conference – East Coast in Atlanta, Georgia, March 2019. Behavioral tests can lead to an ASD diagnosis in children as young as 24 months old, but the average age of diagnosis in the United States is more than 4[…]

Read more

How can I get the NPDX ASD test now?

How to Order

You can find more information in our FAQs.

Parents FAQs
Providers FAQs

Read our paper, published in Biology Psychiatry, which details the results of our clinical study.

Publication: September 2018

© 2019 NeuroPointDX All rights reserved. CLIA #: 52D2122420

Powered by Stemina Biomarker Discovery